175 related articles for article (PubMed ID: 12434015)
1. Cell surface CCR5 density determines the postentry efficiency of R5 HIV-1 infection.
Lin YL; Mettling C; Portales P; Reynes J; Clot J; Corbeau P
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15590-5. PubMed ID: 12434015
[TBL] [Abstract][Full Text] [Related]
2. The efficiency of R5 HIV-1 infection is determined by CD4 T-cell surface CCR5 density through G alpha i-protein signalling.
Lin YL; Mettling C; Portalès P; Réant B; Robert-Hebmann V; Reynes J; Clot J; Corbeau P
AIDS; 2006 Jun; 20(10):1369-77. PubMed ID: 16791011
[TBL] [Abstract][Full Text] [Related]
3. HIV envelope proteins differentially utilize CXCR4 and CCR5 coreceptors for induction of apoptosis.
Yao Q; Compans RW; Chen C
Virology; 2001 Jun; 285(1):128-37. PubMed ID: 11414813
[TBL] [Abstract][Full Text] [Related]
4. CD4+ T cell surface CCR5 density as a determining factor of virus load in persons infected with human immunodeficiency virus type 1.
Reynes J; Portales P; Segondy M; Baillat V; André P; Réant B; Avinens O; Couderc G; Benkirane M; Clot J; Eliaou JF; Corbeau P
J Infect Dis; 2000 Mar; 181(3):927-32. PubMed ID: 10720514
[TBL] [Abstract][Full Text] [Related]
5. Increased CD4 and CCR5 expression and human immunodeficiency virus type 1 entry in CD40 ligand-stimulated macrophages.
Bergamini A; Bolacchi F; Pesce CD; Carbone M; Cepparulo M; Demin F; Rocchi G
J Infect Dis; 2002 Jun; 185(11):1567-77. PubMed ID: 12023762
[TBL] [Abstract][Full Text] [Related]
6. R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism.
Blanco J; Barretina J; Clotet B; Esté JA
J Leukoc Biol; 2004 Oct; 76(4):804-11. PubMed ID: 15258189
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.
Dubey S; Khalid M; Wesley C; Khan SA; Wanchu A; Jameel S
J Clin Virol; 2008 Sep; 43(1):25-31. PubMed ID: 18462992
[TBL] [Abstract][Full Text] [Related]
8. Galphai protein-dependant extracellular signal-regulated kinase-1/2 activation is required for HIV-1 reverse transcription.
Mettling C; Desmetz C; Fiser AL; Réant B; Corbeau P; Lin YL
AIDS; 2008 Aug; 22(13):1569-76. PubMed ID: 18670215
[TBL] [Abstract][Full Text] [Related]
9. M1 and M2a polarization of human monocyte-derived macrophages inhibits HIV-1 replication by distinct mechanisms.
Cassol E; Cassetta L; Rizzi C; Alfano M; Poli G
J Immunol; 2009 May; 182(10):6237-46. PubMed ID: 19414777
[TBL] [Abstract][Full Text] [Related]
10. Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D).
Marozsan AJ; Kuhmann SE; Morgan T; Herrera C; Rivera-Troche E; Xu S; Baroudy BM; Strizki J; Moore JP
Virology; 2005 Jul; 338(1):182-99. PubMed ID: 15935415
[TBL] [Abstract][Full Text] [Related]
11. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
12. Constitutive association of cell surface CCR5 and CXCR4 in the presence of CD4.
Wang J; Alvarez R; Roderiquez G; Guan E; Norcross MA
J Cell Biochem; 2004 Nov; 93(4):753-60. PubMed ID: 15660419
[TBL] [Abstract][Full Text] [Related]
13. Lack of alternative coreceptor use by pediatric HIV-1 R5 isolates for infection of primary cord or adult peripheral blood mononuclear cells.
Sullivan WM; Dorr P; Perros M; Hudson R; Leif J; Luzuriaga K; Clapham PR
Arch Virol; 2008; 153(2):363-6. PubMed ID: 18074097
[TBL] [Abstract][Full Text] [Related]
14. T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery.
Swan CH; Bühler B; Steinberger P; Tschan MP; Barbas CF; Torbett BE
Gene Ther; 2006 Oct; 13(20):1480-92. PubMed ID: 16738691
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of CCR5-mediated infection by diverse R5 and R5X4 HIV and SIV isolates using novel small molecule inhibitors of CCR5: effects of viral diversity, target cell and receptor density.
Willey S; Peters PJ; Sullivan WM; Dorr P; Perros M; Clapham PR
Antiviral Res; 2005 Nov; 68(2):96-108. PubMed ID: 16157392
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of HIV-1 replication in primary human T cells transduced with an intracellular anti-HIV-1 p17 antibody gene.
Tewari D; Notkins AL; Zhou P
J Gene Med; 2003 Mar; 5(3):182-9. PubMed ID: 12666184
[TBL] [Abstract][Full Text] [Related]
17. R5 variants of human immunodeficiency virus type 1 preferentially infect CD62L- CD4+ T cells and are potentially resistant to nucleoside reverse transcriptase inhibitors.
Gondois-Rey F; Biancotto A; Fernandez MA; Bettendroffer L; Blazkova J; Trejbalova K; Pion M; Hirsch I
J Virol; 2006 Jan; 80(2):854-65. PubMed ID: 16378987
[TBL] [Abstract][Full Text] [Related]
18. Complete knockdown of CCR5 by lentiviral vector-expressed siRNAs and protection of transgenic macrophages against HIV-1 infection.
Anderson J; Akkina R
Gene Ther; 2007 Sep; 14(17):1287-97. PubMed ID: 17597795
[TBL] [Abstract][Full Text] [Related]
19. Expression of the dengue virus type 2 NS5 protein in a CD4(+) T cell line inhibits HIV replication.
McLinden JH; Stapleton JT; Chang Q; Xiang J
J Infect Dis; 2008 Sep; 198(6):860-3. PubMed ID: 18721058
[TBL] [Abstract][Full Text] [Related]
20. Persistent resistance to HIV-1 infection in CD4 T cells from exposed uninfected Vietnamese individuals is mediated by entry and post-entry blocks.
Sáez-Cirión A; Versmisse P; Truong LX; Chakrabarti LA; Carpentier W; Barré-Sinoussi F; Scott-Algara D; Pancino G
Retrovirology; 2006 Nov; 3():81. PubMed ID: 17092330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
